Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Better Therapeutics Inc (NQ: BTTX )

0.7001 +0.0003 (+0.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125,829
Open 0.6413
Bid (Size) 0.6800 (2)
Ask (Size) 0.8151 (1)
Prev. Close 0.6998
Today's Range 0.6400 - 0.7649
52wk Range 0.5890 - 2.800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Better Therapeutics: Q1 Earnings Insights
 
Via Benzinga
Better Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire

Performance

YTD
-36.35%
-36.35%
1 Month
-38.04%
-38.04%
3 Month
-41.66%
-41.66%
6 Month
-51.04%
-51.04%
1 Year
-61.32%
-61.32%

More News

Read More
Better Therapeutics's Earnings: A Preview
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Better Therapeutics to Release First Quarter 2023 Financial Results and Provide Business Update on May 11, 2023
From Better Therapeutics, Inc.
Via Business Wire
A Preview Of Better Therapeutics's Earnings
Via Benzinga
Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Better Therapeutics Announces $6.5MM Private Placement
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Better Therapeutics to Release Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 30, 2023
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Participate in Two Upcoming Investor Conferences
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Posts Encouraging Data Establishing Proof-Of-Concept For Prescription Digital Therapy Platform
Via Benzinga
Better Therapeutics Completes Exploratory Trial for Fatty Liver Disease and Announces Positive Topline Results
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Participate in BTIG Digital Health Forum
From Better Therapeutics, Inc.
Via Business Wire
PDS Biotechnology To Rally Around 129%? Here Are 5 Other Price Target Changes For Tuesday
Via Benzinga
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
From Better Therapeutics, Inc.
Via Business Wire
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
From Better Therapeutics, Inc.
Via Business Wire
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market
Via InvestorPlace
Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care
From Better Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.